eMedicine Specialties > Emergency Medicine > Ear, Nose, & Throat

Pharyngitis

Author: John R Acerra, MD, Resident Physician, Department of Emergency Medicine, Allegheny General Hospital
Coauthor(s): Andrew A Aronson, MD, Assistant Professor of Emergency Medicine, Drexel University School of Medicine; Consulting Staff, Department of Emergency Medicine, Allegheny General Hospital
Contributor Information and Disclosures

Updated: Nov 5, 2007

Introduction

Background

Pharyngitis is defined as an infection or irritation of the pharynx and/or tonsils. The etiology is usually infectious, with 40-60% of cases being of viral origin and 5-40% of cases being of bacterial origin. Other causes include allergy, trauma, toxins, and neoplasia.

The main ED concerns with pharyngitis are to rule out more serious conditions, such as epiglottitis or peritonsillar abscess, and to diagnose group A beta-hemolytic streptococcal (GABHS) infections. GABHS infections can have serious sequelae and represent approximately 15% of all ED pharyngitis visits.

Pathophysiology

With infectious pharyngitis, bacteria or viruses may directly invade the pharyngeal mucosa, causing a local inflammatory response. Other viruses, such as rhinovirus, can cause irritation of pharyngeal mucosa secondary to nasal secretion.

Streptococcal infections are characterized by local invasion and release of extracellular toxins and proteases. In addition, M protein fragments of certain serotypes of GABHS are similar to myocardial sarcolemma antigens and are linked to rheumatic fever and subsequent heart valve damage. Acute glomerulonephritis may result from antibody-antigen complex deposition in glomeruli.

Frequency

United States

Children experience more than 5 upper respiratory infections (URIs) per year and an average of one streptococcal infection every 4 years. The occurrence in adults is about one half that rate. The most significant bacterial agent causing pharyngitis in both adults and children is GABHS infection (Streptococcus pyogenes), and the most common viruses are rhinovirus and adenovirus. GABHS is most prevalent in late fall through early spring.

International

The incidence of pharyngitis is higher internationally. Antibiotic resistance may be more prevalent in some countries because of overprescription of antibiotics. It should be noted, however, that there has never been a documented case of GABHS resistant to penicillin anywhere in the world.

Mortality/Morbidity

  • One in 400 cases of untreated GABHS infections can be expected to result in acute rheumatic fever. This rate is higher in less developed countries and might actually be lower in the Western world.
  • Other sequelae of streptococcal pharyngitis include acute glomerulonephritis, peritonsillar abscess, and toxic shock syndrome.
  • Mortality from pharyngitis is rare but may result from one of its complications. For the ED physician, airway obstruction is a concern.

Age

Pharyngitis occurs with much greater frequency in the pediatric population. GABHS is also more common in school-aged children. GABHS causes less than 15% of all adult cases of pharyngitis and about 15-30% of pediatric cases. 

  • The peak incidence of bacterial and viral pharyngitis occurs in the school-aged child aged 4-7 years.
  • Pharyngitis, especially GABHS infection, is rare in children younger than 3 years.
  • Mycoplasma pneumoniae, Chlamydia pneumoniae, and Arcanobacterium haemolyticus peak as causative agents in people in the teen years through the young adulthood years.

Clinical

History

A clinical diagnosis of GABHS infection results in an overestimation of incidence by as much as 80%. Many bacterial and viral cases of pharyngitis can be indistinguishable on clinical grounds. However, the classic presentations are described below.

  • GABHS infection is most common in children aged 4-7 year.
  • Sudden onset is consistent with a GABHS pharyngitis. Pharyngitis following several days of coughing or rhinorrhea is more consistent with a viral etiology.
  • Person has been in contact with others diagnosed with GABHS or rheumatic fever.
  • Headache is consistent with GABHS or Mycoplasma infection.
  • Cough is not usually associated with GABHS infection.
  • Vomiting is associated with GABHS infection but may be present in other types of pharyngitis.
  • A history of recent orogenital contact suggests the possibility of gonococcal pharyngitis.
  • A history of rheumatic fever is important when considering treatment.

Physical

  • Airway patency must be assessed and addressed first.
  • Temperature
    • Fever is usually absent or low-grade in viral pharyngitis, but fever is not reliable to differentiate viral or bacterial etiologies.
    • Temperature can be as high as 106°F with coxsackievirus A, coxsackievirus B, herpes simplex, GABHS infection, human immunodeficiency virus 1 (HIV-1), infectious mononucleosis, and cytomegalovirus (CMV).
  • Hydration status: Oral intake usually is compromised because of odynophagia; therefore, various degrees of dehydration result.
  • Head, ears, eyes, nose, and throat (HEENT)
    • Conjunctivitis may be seen in association with adenovirus.
    • Scleral icterus may be seen with infectious mononucleosis.
    • Rhinorrhea usually is associated with a viral cause.
    • Tonsillopharyngeal/palatal petechiae are seen in GABHS infections and infectious mononucleosis.
    • A tonsillopharyngeal exudate may be seen in streptococcal infectious mononucleosis and occasionally in M pneumoniae, C pneumoniae, A haemolyticus, adenovirus, and herpesvirus infections. Therefore, exudate does not differentiate viral and bacterial causes.
    • Oropharyngeal vesicular lesions are seen in coxsackievirus and herpesvirus. Concomitant vesicles on the hands and feet are associated with coxsackievirus (hand-foot-and-mouth disease).
  • Lymphadenopathy: Tender anterior cervical nodes are consistent with streptococcal infection, while generalized adenopathy is consistent with infectious mononucleosis or the acute lymphoglandular syndrome of HIV infection.
  • Cardiovascular: Murmurs should be documented in an acute episode of pharyngitis to monitor for potential rheumatic fever.
  • Pulmonary: Pharyngitis and lower respiratory tract infections are more consistent with M pneumoniae or C pneumoniae, particularly when a persistent nonproductive cough is present.
  • Abdomen: Hepatosplenomegaly can be found in infectious mononucleosis infection.
  • Skin
    • A sandpapery scarlatiniform rash is seen in GABHS infection (see Scarlet Fever).
    • Maculopapular rashes are seen with various viral infections and with infectious mononucleosis empirically treated with penicillin.

Causes

  • Bacterial pharyngitis
    • Group A beta-hemolytic streptococci (15% of all pharyngitis)
      • The classic clinical picture includes a fever, temperature of greater than 101.5°F, tonsillopharyngeal erythema and exudate, swollen tender anterior cervical adenopathy, headache, emesis in children, palatal petechiae, midwinter to early spring season, and absent cough or rhinorrhea.
      • A scarlatiniform rash also is associated with GABHS infection (scarlet fever), ie, a sandpaperlike erythematous rash over the trunk and extremities with circumoral pallor and a strawberry tongue.
    • Group C, G, and F streptococci (10%) may be indistinguishable clinically from GABHS infection. Acute glomerulonephritis is an extremely unusual complication of group C streptococcal pharyngitis, but a relationship between group G streptococcal pharyngitis and acute glomerulonephritis has not be established. Acute rheumatic fever has not been described as a complication of either. They may be associated with food-borne outbreaks. Group C streptococci have been reported to cause meningitis, endocarditis, and subdural empyemas.
    • Arcanobacterium (Corynebacterium) haemolyticus (5%) is more common in young adults and is very similar to GABHS infection, including a similar scarlatiniform rash. Patients often have a cough. Occasional outbreaks have been reported.
    • M pneumoniae in young adults presents with headache, pharyngitis, and lower respiratory symptoms. Approximately 75% of patients have a cough, which is distinctive from GABHS infection.
    • C pneumoniae (5%) has a clinical picture similar to that of M pneumoniae. Pharyngitis usually precedes the pulmonary infection by about 1-3 weeks.
    • Neisseria gonorrhoeae is a rare cause of pharyngitis. A careful history is important since infection usually follows orogenital contact. It may be associated with severe systemic infection.
    • Corynebacterium diphtheriae is rare in the United States. A foul smelling gray-white pharyngeal membrane may result in airway obstruction.
    • Unusual bacteria that could present with pharyngitis include Borrelia species, Francisella tularensis, Yersinia species, and Corynebacterium ulcerans.
  • Viral pharyngitis
    • Adenovirus (5%): The distinguishing feature of an adenovirus infection is conjunctivitis associated with pharyngitis (pharyngoconjunctival fever). It is the most common etiology in children younger than 3 years.
    • Herpes simplex (5%): Vesicular lesions (herpangina), especially in young children, are the hallmark. In older patients, pharyngitis may be indistinguishable from GABHS infection.
    • Coxsackieviruses A and B (5%): These infections present similarly to herpes simplex, and vesicles may be present. If vesicles are whitish and nodular, it is known as lymphonodular pharyngitis. Coxsackievirus A16 may cause hand-foot-and-mouth disease, which presents with 4- to 8-mm oropharyngeal ulcers and vesicles on the hands and feet, and, occasionally, on the buttocks. The oropharyngeal ulcers and vesicles resolve within 1 week.
    • Epstein-Barr virus (EBV): Clinically known as infectious mononucleosis, it is extremely difficult to distinguish from GABHS infection. Exudative pharyngitis is prominent. Distinctive features include retrocervical or generalized adenopathy and hepatosplenomegaly. Atypical lymphocytes can be seen on peripheral blood smear. Viral cultures from washings are about 20% sensitive in adults.
    • CMV: Presentation of CMV is similar to the presentation of infectious mononucleosis. Patients tend to be older, are sexually active, and have higher fever and more malaise. Pharyngitis may not be a prominent complaint.
    • HIV-1: This is associated with pharyngeal edema and erythema, common aphthous ulcers, and a rarity of exudates. Fever, myalgia, and lymphadenopathy also are found.
  • Other causes of pharyngitis
    • Oral thrush is due to candidal species, usually in patients who are immunocompromised. It may be common in young children and presents with whitish plaques in the oropharynx.
    • Other causes include dry air, allergy/postnasal drip, chemical injury, gastroesophageal reflux disease (GERD), smoking, neoplasia, and endotracheal intubation.

More on Pharyngitis

Overview: Pharyngitis
Differential Diagnoses & Workup: Pharyngitis
Treatment & Medication: Pharyngitis
Follow-up: Pharyngitis
References

References

  1. Bisno AL. Acute pharyngitis: etiology and diagnosis. Pediatrics. Jun 1996;97(6 Pt 2):949-54. [Medline].

  2. Bisno AL, Gerber MA, Gwaltney JM Jr, Kaplan EL, Schwartz RH. Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Infectious Diseases Society of America. Clin Infect Dis. Jul 15 2002;35(2):113-25. [Medline].

  3. Blumer JL, Goldfarb J. Meta-analysis in the evaluation of treatment for streptococcal pharyngitis: a review. Clin Ther. Jul-Aug 1994;16(4):604-20; discussion 603. [Medline].

  4. Cohen R, Levy C, Doit C, De La Rocque F, Boucherat M, Fitoussi F, et al. Six-day amoxicillin vs. ten-day penicillin V therapy for group A streptococcal tonsillopharyngitis. Pediatr Infect Dis J. Aug 1996;15(8):678-82. [Medline].

  5. Del Mar CB, Glasziou PP, Spinks AB. Antibiotics for sore throat (Review). The Cochrane Collaboration. 2007;(1):1-41.

  6. Denny FW Jr. Tonsillopharyngitis 1994. Pediatr Rev. May 1994;15(5):185-91. [Medline].

  7. Edmond KM, Grimwood K, Carlin JB, Chondros P, Hogg GG, Barnett PL. Streptococcal pharyngitis in a paediatric emergency department. Med J Aust. Oct 21 1996;165(8):420-3. [Medline].

  8. Gerber MA. Diagnosis and treatment of pharyngitis in children. Pediatr Clin North Am. Jun 2005;52(3):729-47, vi. [Medline].

  9. Kline JA, Runge JW. Streptococcal pharyngitis: a review of pathophysiology, diagnosis, and management. J Emerg Med. Sep-Oct 1994;12(5):665-80. [Medline].

  10. Mainous AG 3rd, Zoorob RJ, Kohrs FP, Hagen MD. Streptococcal diagnostic testing and antibiotics prescribed for pediatric tonsillopharyngitis. Pediatr Infect Dis J. Sep 1996;15(9):806-10. [Medline].

  11. McIsaac WJ, Goel V, Slaughter PM, Parsons GW, Woolnough KV, Weir PT, et al. Reconsidering sore throats. Part I: Problems with current clinical practice. Can Fam Physician. Mar 1997;43:485-93. [Medline].

  12. Meland E, Digranes A, Skjaerven R. Assessment of clinical features predicting streptococcal pharyngitis. Scand J Infect Dis. 1993;25(2):177-83. [Medline].

  13. Middleton DB. Pharyngitis. Prim Care. Dec 1996;23(4):719-39. [Medline].

  14. Pichichero M, Casey J. Comparison of European and U.S. results for cephalosporin versus penicillin treatment of group A streptococcal tonsillopharyngitis. Eur J Clin Microbiol Infect Dis. Jun 2006;25(6):354-64. [Medline].

  15. Pichichero ME. Group A streptococcal tonsillopharyngitis: cost-effective diagnosis and treatment. Ann Emerg Med. Mar 1995;25(3):390-403. [Medline].

  16. Pichichero ME. Pathogen shifts and changing cure rates for otitis media and tonsillopharyngitis. Clin Pediatr (Phila). Jul 2006;45(6):493-502. [Medline].

  17. Pichichero ME. Sore throat after sore throat after sore throat. Are you asking the critical questions?. Postgrad Med. Jan 1997;101(1):205-6, 209-12, 215-8, passim. [Medline].

  18. Scaglione F, Demartini G, Arcidiacono MM, Pintucci JP. Optimum treatment of streptococcal pharyngitis. Drugs. Jan 1997;53(1):86-97. [Medline].

  19. Shulman ST. Complications of streptococcal pharyngitis. Pediatr Infect Dis J. Jan 1994;13(1 Suppl 1):S70-4; discussion S78-9. [Medline].

  20. Smith DS. Current concepts in the management of pharyngitis. Compr Ther. Dec 1996;22(12):806-9. [Medline].

  21. Talan DA. Infectious disease issues in the emergency department. Clin Infect Dis. Jul 1996;23(1):1-12, quiz 13-4. [Medline].

  22. Van Howe RS, Kusnier LP 2nd. Diagnosis and management of pharyngitis in a pediatric population based on cost-effectiveness and projected health outcomes. Pediatrics. Mar 2006;117(3):609-19. [Medline].

Further Reading

Contributor Information and Disclosures

Author

John R Acerra, MD, Resident Physician, Department of Emergency Medicine, Allegheny General Hospital
John R Acerra, MD is a member of the following medical societies: Air Medical Physician Association, American College of Emergency Physicians, American Medical Association, Emergency Medicine Residents Association, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Coauthor(s)

Andrew A Aronson, MD, Assistant Professor of Emergency Medicine, Drexel University School of Medicine; Consulting Staff, Department of Emergency Medicine, Allegheny General Hospital
Andrew A Aronson, MD is a member of the following medical societies: American College of Emergency Physicians, Massachusetts Medical Society, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Medical Editor

Jerry Balentine, DO, Professor of Emergency Medicine, New York College of Osteopathic Medicine; Senior Vice President, Chief Medical Officer, Medical Director, Attending Physician in Department of Emergency Medicine, Saint Barnabas Hospital
Jerry Balentine, DO is a member of the following medical societies: American College of Emergency Physicians, American College of Osteopathic Emergency Physicians, American College of Physician Executives, American Osteopathic Association, and New York Academy of Medicine
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Mark W Fourre, MD, Program Director, Department of Emergency Medicine, Maine Medical Center; Associate Clinical Professor, Department of Surgery, University of Vermont School of Medicine
Disclosure: Nothing to disclose.

CME Editor

John Halamka, MD, Chief Information Officer, CareGroup Healthcare System, Assistant Professor of Medicine, Department of Emergency Medicine, Beth Israel Deaconess Medical Center; Assistant Professor of Medicine, Harvard Medical School
John Halamka, MD is a member of the following medical societies: American Academy of Emergency Medicine and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Chief Editor

Pamela L Dyne, MD, Associate Professor, Program Director, Department of Medicine, Division of Emergency Medicine, University of California at Los Angeles School of Medicine
Pamela L Dyne, MD is a member of the following medical societies: American College of Emergency Physicians and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.